3,6-diethyl 4-oxo-1,4-dihydroquinoline-3,6-dicarboxylate, 97%, 100mg

N-Butylsulfonamide, 97.0%, 5g

N,N-Diisopropylethylamine (DIPEA), 100mL, >=99.5%, for peptide synthesis, glass packaging

3-(2,3-Dihydro-1h-indole-1-sulfonyl)benzoic acid, 95%, 50mg

2,4-DIFLUORO-6-METHOXYBENZONITRILE, 95.0%, 250mg

(S,S)-cis-1-N-Boc-4-Hydroxy-proline, 95.0%, 5g

Cyclopropyl trifluoromethanesulfonate, 95.0%, 1g

2-Methyl-1H-indole-4-carboxylic acid, 97%, 250mg

METHYL 4-OXO-4,5,6,7-TETRAHYDRO-2H-ISOINDOLE-1-CARBOXYLATE, 95.0%, 500mg

1-Methylpiperazin-2-one hydrochloride, 95.0%, 5g

2-ethyl-1-(3-methylpiperazin-1-yl)hexan-1-one, 95.0%, 2g

4-(2,5-Dioxo-imidazolidin-1-yl)-butyric acid, 100mg

2-(2-Quinoxalinyl)malondialdehyde, 95.0%, 25g